通过准细胞壁核组装蛋白CpsA,ACA可以杀死结核菌和M. bovis
Feng Huang1, Mengcong Shi1, Liu Chen1
1National Key Laboratory of Agricultural Microbiology, College of Life Science and Technology, Huazhong Agricultural University, Wuhan, China.
一种新的化合物,3-azidothiophene-2-carboxylic acid (ACA),通过破坏其细胞壁组装,有效地杀死结核菌菌. ACA针对CpsA1和CpsA2酶,提供了对抗耐药结核病的潜在策略.
科学领域:
- 微生物学 微生物学
- 药物发现 药物发现 药物发现
- 生物化学 生物化学
背景情况:
- 结核病 (TB) 仍然是一个全球性健康威胁,由多药耐药菌株加剧.
- 迫切需要新的抗结核病药物和药物点来对抗耐药的Mycobacterium结核病.
- 细菌细胞壁是抗结核药物开发的关键目标.
研究的目的:
- 识别新的抗结核化合物及其分子标.
- 为了研究3-azidothiophene-2-carboxylic acid (ACA) 的作用机制.
- 探索CpsA1和CpsA2作为结核病治疗的潜在药物标.
主要方法:
- 全基因组测序ACA耐药的Mycobacterium结核病突变菌.
- 在突变菌株和受治疗菌株中分析细胞壁完整性和透性.
- 酶活性测定用于评估ACA对CpsA1和CpsA2酸盐酶活性的抑制.
主要成果:
- ACA通过抑制细胞壁核心组装来杀死Mycobacterium结核菌.
- 在cpsA2基因中的突变赋予了对ACA的抗性,突出显示了它在细胞壁合成中的作用.
- ACA直接结合并抑制CpsA1和CpsA2酶的酸盐酶活性.
- 删除cpsA1或cpsA2同类物会增加细胞壁的透性和药物敏感性.
结论:
- 3-azidothiophene-2-carboxylic acid (ACA) 是一种强大的抗结核病化合物,向CpsA1和CpsA2.
- ACA 干扰了菌根菌细胞壁中的阿拉比诺和丁糖的共价附着.
- 验证了CpsA1和CpsA2作为开发新的抗结核疗法,特别是耐药菌株的有希望的药物标.
更多相关视频
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
相关概念视频
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Bacterial Phylum Actinobacteria
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
